IRCT20200421047155N1招募中3 期
Therapeutic Effect of Tenofovir and hydroxychloroquine combination therapy compared to chloroquine alone in patients with COVID-19
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 入组人数
- 86
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 80 years（—）
- 性别
- All
入选标准
- •Patients with COVID-19 pulmonary infection
- •Established diagnosis of COVID-19 with RTPCR
- •Patients older than 18 years
排除标准
- •Reinfection with COVID-19
- •Patients with immunodeficiency
- •Individuals who are reluctant to participate in study
- •Prior history of allergy to used drugs
- •Documented history of any other medical condition for which the patient require to use a certain medication routinely.
- •Creatinin clearance less than 30 mg/min
- •Oxygen Saturation (SpO2) less than 40%
- •ICU patients
研究者
相似试验
已完成
不适用
Tenofovir-DF Versus Hydroxychloroquine in the Treatment of Hospitalized Patients With COVID-19 (TEDHICOV)Covid19SARS-CoV InfectionTenofovirNCT04812496Hospital Nacional Carlos Alberto Seguin Escobedo - EsSalud100
已完成
2 期
Clinical trial study on the therapeutic effect of Tenofovir besides routine drug regime (standard of care) in patients with Coronavirus disease 2019 (COVID-19)covid-19.Covid-19, confirmed cases, positive test resultU07.1IRCT20200422047168N1Ahvaz University of Medical Sciences60
已完成
不适用
Remdesevir and Hydroxychloroquine in moderate to severe Covid 19 patient.CTRI/2021/02/031430I50
已完成
4 期
Effectiveness and Safety of Tenofovir + Lamivudine + Efavirenz Generic Scheme for the Treatment of HIV Infection / AIDS in Patients of the CLS,Colombia, 2012-2013.HIV/AIDSRPCEC00000134Corporación de Lucha Contra el Sida80
已完成
3 期
Comparative study between Entecavir and Tenofovir in the treatment of chronic hepatitis B infection in Thai patientsChronic hepatitis B infectionChronic hepatitis B,Tenofovir,Entecavir,Efficacy,SafetyTCTR20180626002Chulabhorn Hospital442